ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

ADCT ADC Therapeutics SA

4.46
0.02 (0.45%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
ADC Therapeutics SA ADCT NYSE 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.02 0.45% 4.46 08:51:24
개장가 저가 고가 종가 전일 종가
4.44 4.21 4.51 4.34 4.44
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
04/04/202420:00GLOBEADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial..
03/04/202420:00GLOBEADC Therapeutics to Host a Virtual Research Investor Event..
02/04/202405:05GLOBEADC Therapeutics Makes Grants to New Employees Under..
13/03/202420:03IHMARKETNEWSMixed Futures Amidst Quiet Economic Schedule; Oil Prices..
13/03/202420:00GLOBEADC Therapeutics Reports Fourth Quarter and Full Year 2023..
06/03/202421:15GLOBEADC Therapeutics to Participate in the Guggenheim 5th Annual..
06/03/202421:00GLOBEADC Therapeutics to Host Fourth Quarter and Year-End 2023..
06/03/202407:45GLOBEADC Therapeutics Announces Abstracts Accepted for..
05/03/202423:15EDGAR2Form 8-K - Current report
01/03/202406:30EDGAR2Form 8-K - Current report
27/02/202421:00GLOBEADC Therapeutics to Participate in the TD Cowen 44th Annual..
24/01/202422:00EDGAR2Form 8-K - Current report
20/01/202406:30EDGAR2Form 8-K - Current report
04/01/202421:15EDGAR2Form 8-K - Current report
04/01/202421:15GLOBEADC Therapeutics Regains Compliance with NYSE Continued..
04/01/202421:00EDGAR2Form 8-K - Current report
04/01/202421:00GLOBEADC Therapeutics Provides Business Updates
03/01/202410:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/01/202410:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/01/202410:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/01/202410:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/01/202409:59EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/01/202409:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
19/12/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/12/202306:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/12/202319:15GLOBEADC Therapeutics Announces Initial Results from..
05/12/202306:57EDGAR2Form S-8 - Securities to be offered to employees in employee..
20/11/202316:40PRNUSSobi to present new data at ASH 2023 Annual Meeting
15/11/202317:00GLOBEMyricx Bio Appoints Dr Chris Martin, Biotech Entrepreneur..
07/11/202321:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202321:15GLOBEADC Therapeutics Receives NYSE Notice of Non-Compliance With..
07/11/202321:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202321:00GLOBEADC Therapeutics Reports Third Quarter 2023 Financial..
06/11/202321:00GLOBEADC Therapeutics to Participate in the Jefferies London..
02/11/202323:10GLOBEADC Therapeutics Announces Abstracts Accepted for..
24/10/202320:00GLOBEADC Therapeutics to Host Third Quarter 2023 Financial..
04/10/202317:00GLOBEMyricx Expands its ADC Expertise with the Appointment of..
11/09/202320:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/09/202320:00GLOBEADC Therapeutics to Participate in September Investor..
31/08/202308:32GLOBEADC Therapeutics Announces Updates on ZYNLONTA® LOTIS..
08/08/202320:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/08/202320:00GLOBEADC Therapeutics Reports Second Quarter 2023 Financial..
01/08/202320:00GLOBEADC Therapeutics to Host Second Quarter 2023 Financial..
24/07/202320:21GLOBEOverland ADCT BioPharma Announces NMPA Accepts Biologics..
21/07/202305:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/07/202305:05GLOBEADC Therapeutics Announces Plan to Discontinue the Phase 2..
11/07/202322:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/07/202320:00GLOBEADC Therapeutics Announces Voluntary Pause of Enrollment in..
15/06/202320:15GLOBEADC Therapeutics Announces Evolution of Board of Directors
09/06/202320:15GLOBEADC Therapeutics Announces Updated LOTIS-2 Results..

최근 히스토리

Delayed Upgrade Clock